clorazepate


Also found in: Wikipedia.

clorazepate

 [klo-raz´ĕ-pāt]
a benzodiazepine compound used as the dipotassium salt as an antianxiety agent, anticonvulsant, and for the treatment of acute alcohol withdrawal symptoms; administered orally.

clorazepate

/clor·az·e·pate/ (klor-az´ĕ-pāt) a benzodiazepine used as the dipotassium salt as an antianxiety agent, anticonvulsant, and aid in the treatment of acute alcohol withdrawal.

clorazepate

Pharmacology An anxiolytic and sedative hypnotic prodrug for nordiazepam

clorazepate

A long-acting BENZODIAZEPINE drug used to treat anxiety. A brand name is Tranxene.

clorazepate

a benzodiazepine compound used in the treatment of seizures in dogs.
References in periodicals archive ?
4 million, the majority of which was to accrue for a contingent legal liability with respect to the lorazepam and clorazepate litigation.
Pursuant to the agreement, Mylan will pay $25 million and a third party will pay an additional $285,000 to settle all claims of third party payers for payments made on behalf of users of lorazepam and clorazepate in 19 states and the District of Columbia.
0 million to accrue for a contingent legal liability with respect to the lorazepam and clorazepate litigation.
Uncovered in the investigation was evidence that Mylan raised the price of clorazepate by about 3,200 percent in January 1998.
Adjusted earnings per diluted share does not include the following items: (1) certain ongoing research and development and marketing costs related to nebivolol (the Company's next-generation beta blocker) that will be incurred until an out-licensing agreement relating to such product is signed, (2) costs, including restructuring costs, related to Mylan Bertek, the subsidiary that Mylan recently announced it was closing, and (3) a contingent legal liability related to previously-disclosed litigation in connection with the Company's lorazepam and clorazepate products.
The above adjusted earnings per diluted share, which is a non-GAAP measure, does not include: (1) certain ongoing research and development and marketing costs related to nebivolol (the Company's next- generation beta blocker) that will be incurred until an out-licensing agreement relating to such product is signed, (2) costs, including restructuring costs, related to Mylan Bertek, the subsidiary that Mylan recently announced it was closing, and (3) a contingent legal liability related to previously-disclosed litigation in connection with the Company's lorazepam and clorazepate products.
Following the exclusive supply agreements, Mylan dramatically raised prices of generic lorazepam and clorazepate tablets, despite no significant increases in its costs.
Food and Drug Administration to manufacture and market Clorazepate Dipotassium Tablets USP, 3.
Notice is hereby given that a class action has been commenced in the Superior Court of the State of California, County of San Diego, on behalf of all persons residing in the State of California who purchased the generic drugs Lorazepam or Clorazepate since January 1, 1998, which are manufactured by Mylan Laboratories, Inc.
Pappert said the funds will be used by the PACE program to pay for the widely prescribed drugs, lorazepam and clorazepate, for Pennsylvania seniors who have no prescription drug coverage.
collectively, "Mylan") and Cambrex Corporation on behalf of purchasers of three generic prescription drugs manufactured by Mylan: Lorazepam, Clorazepate Potassium ("Clorazepate") and Methyclothiazide.